Psychopharmacology PNLE Questions

Introduction

This Psychopharmacology page contains exactly 8 live published Tangerine practice questions. The set includes 4 hard and 4 medium items, so use it to check reasoning rather than to forecast an exam result. The inventory was last updated August 12, 2026.

Within NP5: Psychiatric, the canonical scope covers psychiatric medications, their mechanisms, monitoring, adverse effects, and adherence. Practice decisions include identifying the medication-related danger, choosing the first nursing assessment or safety action, distinguishing an expected time course from an urgent adverse effect, and checking whether the patient can follow the regimen safely.

Psychopharmacology is a Tangerine pedagogical lens mapped across relevant competencies in the official five-subject PNLE TOS. It is not a separate official test subject, and the 2025 Enhanced TOS does not assign a guaranteed microtopic count to this lens. Adjacent practice areas are Somatic Therapies and Substance Use Disorders, while ECT, other somatic procedures, and nonpsychiatric medications are outside this page.

Key concepts

Link mechanism to the safety profile
Recognize: A medication class predicts useful effects and characteristic risks: benzodiazepines enhance inhibitory GABA-A activity, SSRIs alter serotonin reuptake, and antipsychotics can produce movement, metabolic, or cardiovascular effects.
Decide: Use the class and the patient’s current cue to select the priority assessment, monitoring plan, and teaching point.
Avoid: Assuming a mechanism guarantees immediate symptom relief or treating a class label as more important than the patient’s airway, circulation, level of consciousness, or behavior.
Benzodiazepine respiratory safety
Recognize: Diazepam and related sedatives can impair alertness and breathing; opioids add central nervous system depression, and sleep apnea increases concern about ventilation during sleep.
Decide: Assess respiratory status, arousability, sedation, and concurrent substances before endorsing use, then escalate concerning findings and reinforce prescribed use only.
Avoid: Calling marked sleepiness harmless, combining sedatives casually, or focusing on anxiety relief while missing slow, shallow, or difficult breathing.
Lithium and fluid-loss cues
Recognize: Dehydration can increase the danger of lithium accumulation, especially when new gastrointestinal or neurologic changes appear.
Decide: Treat the combination of fluid loss and possible toxicity as a priority: assess, protect safety, notify the prescriber promptly, and follow instructions about further doses and testing.
Avoid: Reassuring the patient that extra water alone solves the problem, waiting for a routine appointment, or inventing a laboratory threshold when the question asks for the next nursing action.
Orthostatic hypotension with olanzapine
Recognize: Dizziness, weakness, or lightheadedness after position change can signal a blood-pressure drop and fall risk.
Decide: Assess symptoms and orthostatic measurements as appropriate, assist with position changes, reduce fall hazards, and report persistent or severe findings.
Avoid: Asking a dizzy patient to walk unassisted, dismissing the finding as nonadherence, or changing the dose independently.
SSRI onset and adherence
Recognize: Antidepressant benefit is not judged from one early dose, while side effects, worsening mood, or new safety concerns still require active follow-up.
Decide: Explain the expected delayed response without promising a fixed timeline, assess adherence and tolerability, and ask directly about worsening symptoms or self-harm thoughts.
Avoid: Telling the patient to stop because improvement is not immediate, promising a precise onset, or treating adherence as simple obedience without exploring barriers.
Clozapine and infection surveillance
Recognize: Fever, sore throat, mouth sores, or other infection cues in a patient taking clozapine require prompt attention because agranulocytosis is a serious risk.
Decide: Assess the patient, report promptly, and confirm required blood monitoring and continuation decisions through the prescriber or governing monitoring process.
Avoid: Waiting for a severe infection, supplying an invented blood-count cutoff, or assuming a previous normal result removes current risk.
AIMS as structured movement monitoring
Recognize: Repetitive facial, tongue, limb, or trunk movements may indicate tardive dyskinesia in a patient exposed to antipsychotics.
Decide: Use the AIMS process as directed, observe systematically, document the findings clearly, and communicate new or worsening movements for evaluation.
Avoid: Recording only the patient’s complaint, labeling every movement without assessment, or treating a single normal observation as proof that risk is absent.

What to expect on the PNLE

The inventory supports several question forms: reassessment after short-term diazepam, interaction and respiratory safety with opioids and sleep apnea, acute lithium toxicity after dehydration, orthostatic hypotension with olanzapine, delayed SSRI onset, clozapine agranulocytosis surveillance, and AIMS documentation for tardive dyskinesia. These forms ask you to connect a medication with a cue, select the priority nursing response, interpret monitoring needs, or judge whether teaching and follow-up are safe.

Its live difficulty distribution is 4 hard and 4 medium. Its Bloom distribution is applying 2, remembering 1, understanding 1, and evaluating 4, so much of this small set asks you to weigh competing cues and defend a priority decision, with some direct recall and explanation.

For an applying item, translate the clinical cue into an immediate assessment, safety action, or teaching response.
For remembering and understanding items, retrieve the medication fact or explain how onset and monitoring affect the plan.
For evaluating items, compare the options, identify the greatest harm, and choose the response that protects the patient while respecting prescriber-directed medication management.

Exact topic distribution varies by exam form. Use these 8 questions to diagnose preparation across the scope, not to infer how many questions any microtopic will receive or to predict exam frequency.

Study tips

Start diagnostically. Answer all 8 questions without notes or rationale. Mark each response as sure, unsure, or guessed, and write the cue that changed your choice. This separates recall gaps from priority errors and gives you a starting baseline.
Use focused retrieval. Build a comparison grid from the missed and uncertain items. Make four columns: medication or class, priority cue, first nursing move, and follow-up teaching.
Example grid:
Diazepam | sedation or respiratory concern | assess breathing and arousability | avoid unsafe combinations
Lithium | fluid loss with possible toxicity | assess and report promptly | follow prescriber guidance
Olanzapine | dizziness on standing | prevent falls and reassess | change position slowly
Clozapine | infection cue | report and verify monitoring | do not ignore symptoms
Close the grid and retrieve the decision rule from memory.
Review rationales and errors. For every wrong answer, state the clinical cue, the unsafe option, and the reason the correct action has priority. Label the error as missing a fact, misreading onset, overlooking a safety interaction, or failing to escalate.
Retry after a gap. Rework the same concepts after a few days without looking at your notes. Change the wording of each cue and explain the action aloud so that recall is not tied to one question stem.
Finish with mixed timed practice. Combine Psychopharmacology items with Somatic Therapies and Substance Use Disorders questions, then review the rationale after timing ends. Track recurring decision errors, not just the number correct.

Common mistakes to avoid

Stopping at expected sedation. A learner may accept drowsiness after diazepam without checking the breathing risk. Opioid use, sleep apnea, difficult arousal, or abnormal respiratory effort shifts the priority to respiratory assessment and prompt escalation.
Missing dehydration as a lithium danger cue. Fluid loss can make possible lithium toxicity more urgent. New gastrointestinal or neurologic changes call for immediate assessment and prescriber notification, not reassurance or a routine follow-up plan.
Expecting an immediate SSRI response. Lack of early improvement does not prove that the medication is ineffective or that the patient is nonadherent. The corrective approach is to assess the prescribed use, tolerability, worsening mood, and safety concerns without promising a fixed onset.
Turning orthostatic symptoms into a medication-change order. Dizziness after standing is first a safety and assessment problem. Assist the patient, reduce fall risk, reassess as appropriate, and report findings rather than independently changing olanzapine.
Waiting for severe infection signs with clozapine. Fever, sore throat, or mouth sores should trigger prompt reporting and verification of required blood monitoring. A prior normal result does not remove the need to respond to current symptoms.
Using AIMS as a casual checklist. Tardive dyskinesia monitoring requires systematic observation and clear documentation of involuntary movements. Do not label every movement automatically, but do communicate new or worsening findings for evaluation.

Try a question

A real Psychopharmacology question from our bank. Give it a shot.

Hard

A patient using opioids who has obstructive sleep apnea is prescribed diazepam for acute anxiety. Which pre-dose finding most strongly supports holding diazepam and contacting the prescriber?

A

Anxiety remains severe despite coached breathing and a quiet environment

B

The last opioid dose was six hours ago and pain remains controlled

C

Oxygen saturation is 96% on supplemental oxygen while the patient is awake

D

The patient is difficult to arouse with shallow respirations at eight per minute

Rationale

Option D is the most clinically significant finding because it indicates serious respiratory depression, a life-threatening adverse effect when combining central nervous system (CNS) depressants such as opioids and benzodiazepines. The patient's shallow respirations at eight per minute, along with being difficult to arouse, signal hypoventilation and decreased level of consciousness. This scenario is a medical emergency. Both opioids and diazepam act as CNS depressants, and their combined use markedly increases the risk of respiratory arrest, especially in patients with conditions like obstructive sleep apnea (OSA) that further compromise respiratory status. Nursing responsibilities per pharmacology guidelines include withholding sedative or opioid medications if hypoventilation, hypoxia, or reduced consciousness occurs, and contacting the prescriber for immediate reassessment rather than administering another sedative.

Table: Key Findings Analysis

Finding	Clinical Risk	Action
Difficult to arouse, shallow respirations (8/min)	High – Severe respiratory depression	Withhold, contact prescriber
Severe anxiety despite non-drug interventions	Not immediately life-threatening	Contact prescriber for guidance, not contraindication
Last opioid 6 hours ago, pain controlled	Stable, no concern	Proceed with caution, monitor
O2 sat 96% on O2, awake	Borderline risk, but not acute	Continue to monitor

Incorrect Options Explained:

A. Anxiety remains severe despite coached breathing and a quiet environment: Severe anxiety is a valid reason to consider anxiolytic medication, but this does not represent a contraindication to diazepam. There is no evidence of acute sedation risk or respiratory compromise. Non-pharmacological interventions have been attempted; this alone is not a "hold and notify" situation.
B. The last opioid dose was six hours ago and pain remains controlled: This finding indicates opioid effects are likely waning and pain is well-managed. There is no current evidence of oversedation or respiratory depression; therefore, no reason to hold the medication solely based on the opioid timing.
C. Oxygen saturation is 96% on supplemental oxygen while the patient is awake: While 96% on oxygen suggests close monitoring is needed due to underlying OSA, this value is not in the immediate danger zone (usually <92% is concerning). The critical risk comes from the potential effects after administering an additional CNS depressant, especially when the baseline is already borderline.

Clinical Reasoning and Evidence:

Patients with OSA and recent opioid use are particularly high-risk for sedation-induced respiratory depression due to compromised airway tone and CNS responsiveness during sleep and sedation.
It is a core pharmacologic safety principle to withhold additional CNS depressants when there are signs of oversedation (such as difficult arousal and slow respirations).
Always prioritize assessment of airway, breathing, and consciousness in pharmacology scenarios, as per standard nursing guidelines (see Udan Green Book).
Memory aid: "SLOW to wake, SLOW to breathe – hold, don't give" when considering sedatives or opioids in at-risk groups.

Videbeck, S. L. (2011). Psychiatric-Mental Health Nursing (5th ed.). Lippincott Williams & Wilkins.
Silvestri, L. A. (2017). Saunders Comprehensive Review for the NCLEX-RN Examination (7th ed.). Elsevier.

References and further reading

PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward.
Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.

How this page is built

The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 12, 2026.

The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.